+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Germany Graves' disease Market 2019-2025

  • ID: 5116622
  • Report
  • February 2020
  • Region: Germany
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
Germany Graves’ disease Market Size, Share & Trends Analysis Report by Diagnosis (Ultrasound, Imaging Tests, Radioactive Iodine Uptake, and Blood Sample), by Treatment (Anti- Thyroid Medication, Radioactive Iodine Therapy, and Surgery) Forecast Period 2019-2025.

Germany Graves’ disease market is growing at a CAGR of around 4.3% during the forecast period. Germany is one of the major players in the European region. The growing patient population in the region is one of the major driving forces of such a huge spending in Germany. Moreover, the growing demand for the quality healthcare services in the region is another factor boosting the market. Increasing prevalence of type-1 diabetes is one of the key factors likely to increase the prevalence of Grave’s disease in the country. This is expected to create opportunities for increased demand of advanced treatment options and in turn influences the Germany Graves’ disease market.

Germany is among the top ten countries across the globe in which the prevalence of type-1 diabetes is on a high. According to the International Diabetes Federation, the number of children and adolescents with type-1 diabetes were 28,600. As the prevalence of such disease increases, it is expected to increase the risk associated with prevalence of Grave’s disease, thereby creating opportunity for the growth of the Germany Graves’ disease market in the near future.

Further, the healthcare expenditure in Germany has also been increasing significantly in the past years, which is expected to be followed in the future. This is expected to be one of the key reasons which increase the inflow of R&D funds in autoimmune diseases such as Grave’s disease in the future. This is expected to create opportunities for the development of the Germany Graves’ disease market over the forecast period.

Research Methodology:

The market study of the Germany Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Germany Graves’ Disease Market Research and Analysis by Diagnosis
2. Germany Graves’ Disease Market Research and Analysis by Treatment

The Report Covers:
  • Comprehensive Research Methodology of the Germany Graves’ disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Germany Graves’ disease market.
  • Insights about market determinants which are stimulating the Germany Graves’ disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown